ZURICH, May 30 (Reuters) - As Novartis considers asset sales that could raise $50 billion, investors are worried any cash raised may give the Swiss drugmaker firepower for another unsuccessful megadeal.
by reutersCOMPANYNEWS via Endless Supplies .Biz - News
No comments:
Post a Comment